These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34838322)

  • 1. World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens.
    Hasso-Agopsowicz M; Lopman BA; Lanata CF; Rogawski McQuade ET; Kang G; Prudden HJ; Khalil I; Platts-Mills JA; Kotloff K; Jit M; Riddle MS; Pavlinac PB; Luz PM; Pitzer VE; Breiman RF; Giersing BK
    Vaccine; 2021 Dec; 39(52):7521-7525. PubMed ID: 34838322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report.
    Hosangadi D; Smith PG; Kaslow DC; Giersing BK;
    Vaccine; 2019 Nov; 37(50):7381-7390. PubMed ID: 29352598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
    Baqar S; Bonavia A; Louis Bourgeois A; Campo JJ; Clifford A; Hanevik K; Hasso-Agopsowicz M; Hausdorff W; Kaminski R; MacLennan CA; Mantis N; Martin LB; Omore R; Pasetti M; Pavlinac P; Phalipon A; Poly F; Porter C; Ramasamy MN; Rogawski McQuade ET; Sztein MB; Walker R
    Vaccine; 2024 Mar; 42(7):1445-1453. PubMed ID: 38036392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.
    O'Ryan M; Vidal R; del Canto F; Carlos Salazar J; Montero D
    Hum Vaccin Immunother; 2015; 11(3):601-19. PubMed ID: 25715096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting.
    Bagamian KH; Anderson JD; Muhib F; Cumming O; Laytner LA; Wierzba TF; Rheingans R
    Lancet Glob Health; 2020 Jan; 8(1):e101-e112. PubMed ID: 31734154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.
    Khalil IA; Troeger C; Blacker BF; Rao PC; Brown A; Atherly DE; Brewer TG; Engmann CM; Houpt ER; Kang G; Kotloff KL; Levine MM; Luby SP; MacLennan CA; Pan WK; Pavlinac PB; Platts-Mills JA; Qadri F; Riddle MS; Ryan ET; Shoultz DA; Steele AD; Walson JL; Sanders JW; Mokdad AH; Murray CJL; Hay SI; Reiner RC
    Lancet Infect Dis; 2018 Nov; 18(11):1229-1240. PubMed ID: 30266330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.
    Khalil I; Walker R; Porter CK; Muhib F; Chilengi R; Cravioto A; Guerrant R; Svennerholm AM; Qadri F; Baqar S; Kosek M; Kang G; Lanata C; Armah G; Wierzba T; Hasso-Agopsowicz M; Giersing B; Louis Bourgeois A
    Vaccine; 2021 Jul; 39(31):4266-4277. PubMed ID: 33965254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
    Banerjee S; Barry EM; Baqar S; Louis Bourgeois A; Campo JJ; Choy RKM; Chakraborty S; Clifford A; Deal C; Estrada M; Fleckenstein J; Hasso-Agopsowicz M; Hausdorff W; Khalil I; Maier N; Mubanga C; Platts-Mills JA; Porter C; Qadri F; Simuyandi M; Walker R; White JA
    Vaccine; 2024 Mar; 42(7):1454-1460. PubMed ID: 38030421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.
    Walker RI; Wierzba TF; Mani S; Bourgeois AL
    Vaccine; 2017 Dec; 35(49 Pt A):6775-6782. PubMed ID: 28987444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aetiology of acute diarrhoea in children in Shanghai, 2015-2018.
    Chang H; Guo J; Wei Z; Huang Z; Wang C; Qiu Y; Xu X; Zeng M
    PLoS One; 2021; 16(4):e0249888. PubMed ID: 33831124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis.
    Anderson JD; Bagamian KH; Muhib F; Amaya MP; Laytner LA; Wierzba T; Rheingans R
    Lancet Glob Health; 2019 Mar; 7(3):e321-e330. PubMed ID: 30784633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.
    Barry E; Cassels F; Riddle M; Walker R; Wierzba T
    Vaccine; 2019 Aug; 37(34):4768-4774. PubMed ID: 31358236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capturing the true burden of Shigella and ETEC: The way forward.
    Khalil I; Troeger CE; Blacker BF; Reiner RC
    Vaccine; 2019 Aug; 37(34):4784-4786. PubMed ID: 30711317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
    Khalil I; Anderson JD; Bagamian KH; Baqar S; Giersing B; Hausdorff WP; Marshall C; Porter CK; Walker RI; Bourgeois AL
    Vaccine; 2023 Nov; 41 Suppl 2():S95-S113. PubMed ID: 37951695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
    Walker RI
    Vaccine; 2015 Feb; 33(8):954-65. PubMed ID: 25482842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection.
    Butkeviciute E; Prudden HJ; Jit M; Smith PG; Kang G; Riddle MS; Lopman BA; Pitzer VE; Lanata CF; Platts-Mills JA; Breiman RF; Giersing BK; Hasso-Agopsowicz M
    Vaccine; 2021 Jul; 39(32):4391-4398. PubMed ID: 34134905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food.
    Pires SM; Fischer-Walker CL; Lanata CF; Devleesschauwer B; Hall AJ; Kirk MD; Duarte AS; Black RE; Angulo FJ
    PLoS One; 2015; 10(12):e0142927. PubMed ID: 26632843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt.
    Wasfy MO; Oyofo BA; David JC; Ismail TF; el-Gendy AM; Mohran ZS; Sultan Y; Peruski LF
    J Health Popul Nutr; 2000 Jun; 18(1):33-8. PubMed ID: 11014768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine value profile for Shigella.
    Hausdorff WP; Anderson JD; Bagamian KH; Bourgeois AL; Mills M; Sawe F; Scheele S; Talaat K; Giersing BK
    Vaccine; 2023 Nov; 41 Suppl 2():S76-S94. PubMed ID: 37827969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.